Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | VKTX | PCVX | ||
| Company | Ascendis Pharma ADR | Viking Thera | Vaxcyte Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 141.96 | 74.49 | 66.48 | ||
| High | 142.36 | 77.68 | 67.08 | ||
| Low | 135.16 | 72.88 | 65.46 | ||
| Last | 137.20 | 76.97 | 65.96 | ||
| Change | -3.90 | +1.21 | +1.41 | ||
| % Change | -2.76% | +1.60% | +2.18% | ||
| Volume | 511,400 | 3,754,200 | 620,600 | ||
| 20-Day Average Volume | 326,075 | 2,697,570 | 702,005 | ||
| Previous Close | 141.10 | 75.76 | 64.55 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 143.15 | 70.52 | 62.29 | ||
| 20-Day Raw Stochastic | 16.25% | 81.81% | 87.53% | ||
| 20-Day Relative Strength | 43.02% | 58.47% | 53.44% | ||
| Weighted Alpha | +47.34 | +79.03 | +30.76 | ||
| Today's Opinion | 24% Buy | 80% Buy | 32% Buy | ||
| Previous Opinion | 40% Buy | 80% Buy | 24% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.96% since 04/26/24 | +3.58% since 04/26/24 | +8.63% since 04/26/24 | ||
| Low | 135.16 on 05/03/24 | 72.88 on 05/03/24 | 58.84 on 04/30/24 | ||
| High | 143.99 on 05/02/24 | 80.38 on 05/01/24 | 67.08 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | -8.23% since 04/03/24 | -1.87% since 04/03/24 | +1.32% since 04/03/24 | ||
| Low | 133.39 on 04/26/24 | 61.64 on 04/19/24 | 58.10 on 04/25/24 | ||
| High | 156.84 on 04/10/24 | 80.38 on 05/01/24 | 67.08 on 05/03/24 | ||
| 3-Month | |||||
| %Chg | -1.84% since 02/02/24 | +228.23% since 02/02/24 | -12.37% since 02/02/24 | ||
| Low | 133.39 on 04/26/24 | 22.69 on 02/05/24 | 58.10 on 04/25/24 | ||
| High | 161.00 on 02/26/24 | 99.41 on 02/28/24 | 82.04 on 02/28/24 | ||
| 6-Month | |||||
| %Chg | +44.96% since 11/03/23 | +629.57% since 11/03/23 | +29.97% since 11/03/23 | ||
| Low | 86.54 on 11/13/23 | 9.34 on 11/10/23 | 46.16 on 11/13/23 | ||
| High | 161.00 on 02/26/24 | 99.41 on 02/28/24 | 82.04 on 02/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,215,406 | 8,353,903 | 7,020,394 | ||
| Shares Outstanding, K | 58,224 | 110,268 | 108,759 | ||
| Annual Sales | 288,670,000 | 0 | 0 | ||
| Annual Net Income | -521,070,000 | -85,900,000 | -402,270,000 | ||
| Last Quarter Sales | 148,660,000 | 0 | 0 | ||
| Last Quarter Net Income | -93,040,000 | -27,360,000 | -180,800,000 | ||
| 60-Month Beta | 0.54 | 1.12 | 0.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.66 on 02/07/24 | -0.26 on 04/24/24 | -1.82 on 02/27/24 | ||
| Latest Earnings Date | 05/02/24 | 04/24/24 | 05/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||